Institutional investors purchased a net $105.0 thousand shares of ORMP during the quarter ended November 2017. This may signal that the smart money is gaining interest in this company as the 2.95% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 22.0 Thousand shares of Oramed Pharmaceuticals In...